SENEX BIOTECHNOLOGY, INC.
Making Cancers Curable
COLUMBIA, United States · Founded 2015 · $2.0M raised
- Headquarters
- COLUMBIA, South Carolina
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2B
- Website
- senexbio.com
- Total Funding
- $2.0M
- Last Round
- $1.6M GrantSep 2022
- Rounds
- 2
About
Senex Biotechnology is a clinical-stage company developing highly selective CDK8/19 Mediator Kinase inhibitors to prevent cancer drug resistance and metastasis. Its lead candidate SNX631-6, an orally available small molecule, targets castration-resistant prostate cancer and breast cancer, supported by Department of Defense and NIH grant funding.
Summary
SENEX BIOTECHNOLOGY, INC. is a Biotech company based in COLUMBIA, United States, founded in 2015. It has raised $2.0M in total across 2 rounds, most recently a $1.6M Grant round in Sep 2022. Investors include National Institutes of Health, National Cancer Institute and National Heart, Lung, and Blood Institute.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Sep 2022
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...